Oculis Holding AG recently reported that its neuroprotective candidate Privosegtor received U.S. FDA Breakthrough Therapy designation for optic neuritis, supported by positive Phase 2 ACUITY data and ...

His devastating diagnosis came after a routine eye examination and subsequent investigations.

Oculis Holding (OCS) is back in focus after the U.S. FDA granted breakthrough therapy designation to its neuroprotective candidate Privosegtor for optic neuritis, supported by positive Phase 2 ACUITY ...

Individuals who are HIV-positive and have ocular syphilis show significant visual acuity improvement following standard anti-syphilitic treatment.

Detailed price information for Garrett Motion Inc (GTX-Q) from The Globe and Mail including charting and trades.

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

Life Biosciences is pushing cellular rejuvenation into the clinic with ER-100, an experimental gene ...

Oculis Holding AG, a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, announced that its ...

When you go for a walk, how does your brain know the difference between a parked car and a moving car? This seemingly simple ...

This transcript has been lightly edited for clarity; captions are auto-generated.

Challenge your vision with this mind-bending optical illusion! In a chaotic grid showcasing the number 34, two reversed numbers, 45 and 85, lie in wait, all to be spotted in just 17 seconds. It's a ...